Global Rosuvastatin Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Rosuvastatin is used along with a proper diet to help lower 'bad' cholesterol and fats (such as LDL, triglycerides) and raise 'good' cholesterol (HDL) in the blood. It belongs to a group of drugs known as 'statins.' It works by reducing the amount of cholesterol made by the liver. Lowering 'bad' cholesterol and triglycerides and raising 'good' cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks.
LPI (LP Information)' newest research report, the “Rosuvastatin Drugs Industry Forecast” looks at past sales and reviews total world Rosuvastatin Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Rosuvastatin Drugs sales for 2023 through 2029. With Rosuvastatin Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rosuvastatin Drugs industry.
This Insight Report provides a comprehensive analysis of the global Rosuvastatin Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rosuvastatin Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Rosuvastatin Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rosuvastatin Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rosuvastatin Drugs.
The global Rosuvastatin Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rosuvastatin Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rosuvastatin Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rosuvastatin Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rosuvastatin Drugs players cover AstraZeneca, Watson, ANGITA and Sun Pharmaceutical Industries, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Rosuvastatin Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Rosuvastatin Drugs market?
What factors are driving Rosuvastatin Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rosuvastatin Drugs market opportunities vary by end market size?
How does Rosuvastatin Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Rosuvastatin is used along with a proper diet to help lower 'bad' cholesterol and fats (such as LDL, triglycerides) and raise 'good' cholesterol (HDL) in the blood. It belongs to a group of drugs known as 'statins.' It works by reducing the amount of cholesterol made by the liver. Lowering 'bad' cholesterol and triglycerides and raising 'good' cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks.
LPI (LP Information)' newest research report, the “Rosuvastatin Drugs Industry Forecast” looks at past sales and reviews total world Rosuvastatin Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Rosuvastatin Drugs sales for 2023 through 2029. With Rosuvastatin Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rosuvastatin Drugs industry.
This Insight Report provides a comprehensive analysis of the global Rosuvastatin Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rosuvastatin Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Rosuvastatin Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rosuvastatin Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rosuvastatin Drugs.
The global Rosuvastatin Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rosuvastatin Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rosuvastatin Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rosuvastatin Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rosuvastatin Drugs players cover AstraZeneca, Watson, ANGITA and Sun Pharmaceutical Industries, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Rosuvastatin Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 5 mg Tablet
- 10 mg Tablet
- 20 mg Tablet
- 40 mg Tablet
- Hyperlipidemia And Mixed Dyslipidemia
- Familial Hypercholesterolemia
- Hypertriglyceridemia
- Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
- Atherosclerosis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Watson
- ANGITA
- Sun Pharmaceutical Industries
What is the 10-year outlook for the global Rosuvastatin Drugs market?
What factors are driving Rosuvastatin Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rosuvastatin Drugs market opportunities vary by end market size?
How does Rosuvastatin Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rosuvastatin Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rosuvastatin Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rosuvastatin Drugs by Country/Region, 2018, 2022 & 2029
2.2 Rosuvastatin Drugs Segment by Type
2.2.1 5 mg Tablet
2.2.2 10 mg Tablet
2.2.3 20 mg Tablet
2.2.4 40 mg Tablet
2.3 Rosuvastatin Drugs Sales by Type
2.3.1 Global Rosuvastatin Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Rosuvastatin Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rosuvastatin Drugs Sale Price by Type (2018-2023)
2.4 Rosuvastatin Drugs Segment by Application
2.4.1 Hyperlipidemia And Mixed Dyslipidemia
2.4.2 Familial Hypercholesterolemia
2.4.3 Hypertriglyceridemia
2.4.4 Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
2.4.5 Atherosclerosis
2.4.6 Others
2.5 Rosuvastatin Drugs Sales by Application
2.5.1 Global Rosuvastatin Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Rosuvastatin Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rosuvastatin Drugs Sale Price by Application (2018-2023)
3 GLOBAL ROSUVASTATIN DRUGS BY COMPANY
3.1 Global Rosuvastatin Drugs Breakdown Data by Company
3.1.1 Global Rosuvastatin Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Rosuvastatin Drugs Sales Market Share by Company (2018-2023)
3.2 Global Rosuvastatin Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Rosuvastatin Drugs Revenue by Company (2018-2023)
3.2.2 Global Rosuvastatin Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Rosuvastatin Drugs Sale Price by Company
3.4 Key Manufacturers Rosuvastatin Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rosuvastatin Drugs Product Location Distribution
3.4.2 Players Rosuvastatin Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ROSUVASTATIN DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Rosuvastatin Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Rosuvastatin Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rosuvastatin Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rosuvastatin Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Rosuvastatin Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rosuvastatin Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rosuvastatin Drugs Sales Growth
4.4 APAC Rosuvastatin Drugs Sales Growth
4.5 Europe Rosuvastatin Drugs Sales Growth
4.6 Middle East & Africa Rosuvastatin Drugs Sales Growth
5 AMERICAS
5.1 Americas Rosuvastatin Drugs Sales by Country
5.1.1 Americas Rosuvastatin Drugs Sales by Country (2018-2023)
5.1.2 Americas Rosuvastatin Drugs Revenue by Country (2018-2023)
5.2 Americas Rosuvastatin Drugs Sales by Type
5.3 Americas Rosuvastatin Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rosuvastatin Drugs Sales by Region
6.1.1 APAC Rosuvastatin Drugs Sales by Region (2018-2023)
6.1.2 APAC Rosuvastatin Drugs Revenue by Region (2018-2023)
6.2 APAC Rosuvastatin Drugs Sales by Type
6.3 APAC Rosuvastatin Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rosuvastatin Drugs by Country
7.1.1 Europe Rosuvastatin Drugs Sales by Country (2018-2023)
7.1.2 Europe Rosuvastatin Drugs Revenue by Country (2018-2023)
7.2 Europe Rosuvastatin Drugs Sales by Type
7.3 Europe Rosuvastatin Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rosuvastatin Drugs by Country
8.1.1 Middle East & Africa Rosuvastatin Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rosuvastatin Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Rosuvastatin Drugs Sales by Type
8.3 Middle East & Africa Rosuvastatin Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rosuvastatin Drugs
10.3 Manufacturing Process Analysis of Rosuvastatin Drugs
10.4 Industry Chain Structure of Rosuvastatin Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rosuvastatin Drugs Distributors
11.3 Rosuvastatin Drugs Customer
12 WORLD FORECAST REVIEW FOR ROSUVASTATIN DRUGS BY GEOGRAPHIC REGION
12.1 Global Rosuvastatin Drugs Market Size Forecast by Region
12.1.1 Global Rosuvastatin Drugs Forecast by Region (2024-2029)
12.1.2 Global Rosuvastatin Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rosuvastatin Drugs Forecast by Type
12.7 Global Rosuvastatin Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Rosuvastatin Drugs Product Portfolios and Specifications
13.1.3 AstraZeneca Rosuvastatin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Watson
13.2.1 Watson Company Information
13.2.2 Watson Rosuvastatin Drugs Product Portfolios and Specifications
13.2.3 Watson Rosuvastatin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Watson Main Business Overview
13.2.5 Watson Latest Developments
13.3 ANGITA
13.3.1 ANGITA Company Information
13.3.2 ANGITA Rosuvastatin Drugs Product Portfolios and Specifications
13.3.3 ANGITA Rosuvastatin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ANGITA Main Business Overview
13.3.5 ANGITA Latest Developments
13.4 Sun Pharmaceutical Industries
13.4.1 Sun Pharmaceutical Industries Company Information
13.4.2 Sun Pharmaceutical Industries Rosuvastatin Drugs Product Portfolios and Specifications
13.4.3 Sun Pharmaceutical Industries Rosuvastatin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sun Pharmaceutical Industries Main Business Overview
13.4.5 Sun Pharmaceutical Industries Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rosuvastatin Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rosuvastatin Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rosuvastatin Drugs by Country/Region, 2018, 2022 & 2029
2.2 Rosuvastatin Drugs Segment by Type
2.2.1 5 mg Tablet
2.2.2 10 mg Tablet
2.2.3 20 mg Tablet
2.2.4 40 mg Tablet
2.3 Rosuvastatin Drugs Sales by Type
2.3.1 Global Rosuvastatin Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Rosuvastatin Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rosuvastatin Drugs Sale Price by Type (2018-2023)
2.4 Rosuvastatin Drugs Segment by Application
2.4.1 Hyperlipidemia And Mixed Dyslipidemia
2.4.2 Familial Hypercholesterolemia
2.4.3 Hypertriglyceridemia
2.4.4 Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
2.4.5 Atherosclerosis
2.4.6 Others
2.5 Rosuvastatin Drugs Sales by Application
2.5.1 Global Rosuvastatin Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Rosuvastatin Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rosuvastatin Drugs Sale Price by Application (2018-2023)
3 GLOBAL ROSUVASTATIN DRUGS BY COMPANY
3.1 Global Rosuvastatin Drugs Breakdown Data by Company
3.1.1 Global Rosuvastatin Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Rosuvastatin Drugs Sales Market Share by Company (2018-2023)
3.2 Global Rosuvastatin Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Rosuvastatin Drugs Revenue by Company (2018-2023)
3.2.2 Global Rosuvastatin Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Rosuvastatin Drugs Sale Price by Company
3.4 Key Manufacturers Rosuvastatin Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rosuvastatin Drugs Product Location Distribution
3.4.2 Players Rosuvastatin Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ROSUVASTATIN DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Rosuvastatin Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Rosuvastatin Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rosuvastatin Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rosuvastatin Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Rosuvastatin Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rosuvastatin Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rosuvastatin Drugs Sales Growth
4.4 APAC Rosuvastatin Drugs Sales Growth
4.5 Europe Rosuvastatin Drugs Sales Growth
4.6 Middle East & Africa Rosuvastatin Drugs Sales Growth
5 AMERICAS
5.1 Americas Rosuvastatin Drugs Sales by Country
5.1.1 Americas Rosuvastatin Drugs Sales by Country (2018-2023)
5.1.2 Americas Rosuvastatin Drugs Revenue by Country (2018-2023)
5.2 Americas Rosuvastatin Drugs Sales by Type
5.3 Americas Rosuvastatin Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rosuvastatin Drugs Sales by Region
6.1.1 APAC Rosuvastatin Drugs Sales by Region (2018-2023)
6.1.2 APAC Rosuvastatin Drugs Revenue by Region (2018-2023)
6.2 APAC Rosuvastatin Drugs Sales by Type
6.3 APAC Rosuvastatin Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rosuvastatin Drugs by Country
7.1.1 Europe Rosuvastatin Drugs Sales by Country (2018-2023)
7.1.2 Europe Rosuvastatin Drugs Revenue by Country (2018-2023)
7.2 Europe Rosuvastatin Drugs Sales by Type
7.3 Europe Rosuvastatin Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rosuvastatin Drugs by Country
8.1.1 Middle East & Africa Rosuvastatin Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rosuvastatin Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Rosuvastatin Drugs Sales by Type
8.3 Middle East & Africa Rosuvastatin Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rosuvastatin Drugs
10.3 Manufacturing Process Analysis of Rosuvastatin Drugs
10.4 Industry Chain Structure of Rosuvastatin Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rosuvastatin Drugs Distributors
11.3 Rosuvastatin Drugs Customer
12 WORLD FORECAST REVIEW FOR ROSUVASTATIN DRUGS BY GEOGRAPHIC REGION
12.1 Global Rosuvastatin Drugs Market Size Forecast by Region
12.1.1 Global Rosuvastatin Drugs Forecast by Region (2024-2029)
12.1.2 Global Rosuvastatin Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rosuvastatin Drugs Forecast by Type
12.7 Global Rosuvastatin Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Rosuvastatin Drugs Product Portfolios and Specifications
13.1.3 AstraZeneca Rosuvastatin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Watson
13.2.1 Watson Company Information
13.2.2 Watson Rosuvastatin Drugs Product Portfolios and Specifications
13.2.3 Watson Rosuvastatin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Watson Main Business Overview
13.2.5 Watson Latest Developments
13.3 ANGITA
13.3.1 ANGITA Company Information
13.3.2 ANGITA Rosuvastatin Drugs Product Portfolios and Specifications
13.3.3 ANGITA Rosuvastatin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ANGITA Main Business Overview
13.3.5 ANGITA Latest Developments
13.4 Sun Pharmaceutical Industries
13.4.1 Sun Pharmaceutical Industries Company Information
13.4.2 Sun Pharmaceutical Industries Rosuvastatin Drugs Product Portfolios and Specifications
13.4.3 Sun Pharmaceutical Industries Rosuvastatin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sun Pharmaceutical Industries Main Business Overview
13.4.5 Sun Pharmaceutical Industries Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Rosuvastatin Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rosuvastatin Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 5 mg Tablet
Table 4. Major Players of 10 mg Tablet
Table 5. Major Players of 20 mg Tablet
Table 6. Major Players of 40 mg Tablet
Table 7. Global Rosuvastatin Drugs Sales by Type (2018-2023) & (K Units)
Table 8. Global Rosuvastatin Drugs Sales Market Share by Type (2018-2023)
Table 9. Global Rosuvastatin Drugs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Rosuvastatin Drugs Revenue Market Share by Type (2018-2023)
Table 11. Global Rosuvastatin Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Rosuvastatin Drugs Sales by Application (2018-2023) & (K Units)
Table 13. Global Rosuvastatin Drugs Sales Market Share by Application (2018-2023)
Table 14. Global Rosuvastatin Drugs Revenue by Application (2018-2023)
Table 15. Global Rosuvastatin Drugs Revenue Market Share by Application (2018-2023)
Table 16. Global Rosuvastatin Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Rosuvastatin Drugs Sales by Company (2018-2023) & (K Units)
Table 18. Global Rosuvastatin Drugs Sales Market Share by Company (2018-2023)
Table 19. Global Rosuvastatin Drugs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Rosuvastatin Drugs Revenue Market Share by Company (2018-2023)
Table 21. Global Rosuvastatin Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Rosuvastatin Drugs Producing Area Distribution and Sales Area
Table 23. Players Rosuvastatin Drugs Products Offered
Table 24. Rosuvastatin Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Rosuvastatin Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Rosuvastatin Drugs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Rosuvastatin Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Rosuvastatin Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Rosuvastatin Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Rosuvastatin Drugs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Rosuvastatin Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Rosuvastatin Drugs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Rosuvastatin Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Americas Rosuvastatin Drugs Sales Market Share by Country (2018-2023)
Table 37. Americas Rosuvastatin Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Rosuvastatin Drugs Revenue Market Share by Country (2018-2023)
Table 39. Americas Rosuvastatin Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Americas Rosuvastatin Drugs Sales by Application (2018-2023) & (K Units)
Table 41. APAC Rosuvastatin Drugs Sales by Region (2018-2023) & (K Units)
Table 42. APAC Rosuvastatin Drugs Sales Market Share by Region (2018-2023)
Table 43. APAC Rosuvastatin Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Rosuvastatin Drugs Revenue Market Share by Region (2018-2023)
Table 45. APAC Rosuvastatin Drugs Sales by Type (2018-2023) & (K Units)
Table 46. APAC Rosuvastatin Drugs Sales by Application (2018-2023) & (K Units)
Table 47. Europe Rosuvastatin Drugs Sales by Country (2018-2023) & (K Units)
Table 48. Europe Rosuvastatin Drugs Sales Market Share by Country (2018-2023)
Table 49. Europe Rosuvastatin Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Rosuvastatin Drugs Revenue Market Share by Country (2018-2023)
Table 51. Europe Rosuvastatin Drugs Sales by Type (2018-2023) & (K Units)
Table 52. Europe Rosuvastatin Drugs Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Rosuvastatin Drugs Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Rosuvastatin Drugs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rosuvastatin Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Rosuvastatin Drugs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Rosuvastatin Drugs Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Rosuvastatin Drugs Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Rosuvastatin Drugs
Table 60. Key Market Challenges & Risks of Rosuvastatin Drugs
Table 61. Key Industry Trends of Rosuvastatin Drugs
Table 62. Rosuvastatin Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Rosuvastatin Drugs Distributors List
Table 65. Rosuvastatin Drugs Customer List
Table 66. Global Rosuvastatin Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Rosuvastatin Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Rosuvastatin Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Rosuvastatin Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Rosuvastatin Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Rosuvastatin Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Rosuvastatin Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Rosuvastatin Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Rosuvastatin Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Rosuvastatin Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Rosuvastatin Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Rosuvastatin Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Rosuvastatin Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Rosuvastatin Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. AstraZeneca Basic Information, Rosuvastatin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. AstraZeneca Rosuvastatin Drugs Product Portfolios and Specifications
Table 82. AstraZeneca Rosuvastatin Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. AstraZeneca Main Business
Table 84. AstraZeneca Latest Developments
Table 85. Watson Basic Information, Rosuvastatin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Watson Rosuvastatin Drugs Product Portfolios and Specifications
Table 87. Watson Rosuvastatin Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Watson Main Business
Table 89. Watson Latest Developments
Table 90. ANGITA Basic Information, Rosuvastatin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. ANGITA Rosuvastatin Drugs Product Portfolios and Specifications
Table 92. ANGITA Rosuvastatin Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. ANGITA Main Business
Table 94. ANGITA Latest Developments
Table 95. Sun Pharmaceutical Industries Basic Information, Rosuvastatin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Sun Pharmaceutical Industries Rosuvastatin Drugs Product Portfolios and Specifications
Table 97. Sun Pharmaceutical Industries Rosuvastatin Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Sun Pharmaceutical Industries Main Business
Table 99. Sun Pharmaceutical Industries Latest Developments
Table 1. Rosuvastatin Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rosuvastatin Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 5 mg Tablet
Table 4. Major Players of 10 mg Tablet
Table 5. Major Players of 20 mg Tablet
Table 6. Major Players of 40 mg Tablet
Table 7. Global Rosuvastatin Drugs Sales by Type (2018-2023) & (K Units)
Table 8. Global Rosuvastatin Drugs Sales Market Share by Type (2018-2023)
Table 9. Global Rosuvastatin Drugs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Rosuvastatin Drugs Revenue Market Share by Type (2018-2023)
Table 11. Global Rosuvastatin Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Rosuvastatin Drugs Sales by Application (2018-2023) & (K Units)
Table 13. Global Rosuvastatin Drugs Sales Market Share by Application (2018-2023)
Table 14. Global Rosuvastatin Drugs Revenue by Application (2018-2023)
Table 15. Global Rosuvastatin Drugs Revenue Market Share by Application (2018-2023)
Table 16. Global Rosuvastatin Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Rosuvastatin Drugs Sales by Company (2018-2023) & (K Units)
Table 18. Global Rosuvastatin Drugs Sales Market Share by Company (2018-2023)
Table 19. Global Rosuvastatin Drugs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Rosuvastatin Drugs Revenue Market Share by Company (2018-2023)
Table 21. Global Rosuvastatin Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Rosuvastatin Drugs Producing Area Distribution and Sales Area
Table 23. Players Rosuvastatin Drugs Products Offered
Table 24. Rosuvastatin Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Rosuvastatin Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Rosuvastatin Drugs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Rosuvastatin Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Rosuvastatin Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Rosuvastatin Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Rosuvastatin Drugs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Rosuvastatin Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Rosuvastatin Drugs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Rosuvastatin Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Americas Rosuvastatin Drugs Sales Market Share by Country (2018-2023)
Table 37. Americas Rosuvastatin Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Rosuvastatin Drugs Revenue Market Share by Country (2018-2023)
Table 39. Americas Rosuvastatin Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Americas Rosuvastatin Drugs Sales by Application (2018-2023) & (K Units)
Table 41. APAC Rosuvastatin Drugs Sales by Region (2018-2023) & (K Units)
Table 42. APAC Rosuvastatin Drugs Sales Market Share by Region (2018-2023)
Table 43. APAC Rosuvastatin Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Rosuvastatin Drugs Revenue Market Share by Region (2018-2023)
Table 45. APAC Rosuvastatin Drugs Sales by Type (2018-2023) & (K Units)
Table 46. APAC Rosuvastatin Drugs Sales by Application (2018-2023) & (K Units)
Table 47. Europe Rosuvastatin Drugs Sales by Country (2018-2023) & (K Units)
Table 48. Europe Rosuvastatin Drugs Sales Market Share by Country (2018-2023)
Table 49. Europe Rosuvastatin Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Rosuvastatin Drugs Revenue Market Share by Country (2018-2023)
Table 51. Europe Rosuvastatin Drugs Sales by Type (2018-2023) & (K Units)
Table 52. Europe Rosuvastatin Drugs Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Rosuvastatin Drugs Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Rosuvastatin Drugs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rosuvastatin Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Rosuvastatin Drugs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Rosuvastatin Drugs Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Rosuvastatin Drugs Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Rosuvastatin Drugs
Table 60. Key Market Challenges & Risks of Rosuvastatin Drugs
Table 61. Key Industry Trends of Rosuvastatin Drugs
Table 62. Rosuvastatin Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Rosuvastatin Drugs Distributors List
Table 65. Rosuvastatin Drugs Customer List
Table 66. Global Rosuvastatin Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Rosuvastatin Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Rosuvastatin Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Rosuvastatin Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Rosuvastatin Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Rosuvastatin Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Rosuvastatin Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Rosuvastatin Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Rosuvastatin Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Rosuvastatin Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Rosuvastatin Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Rosuvastatin Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Rosuvastatin Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Rosuvastatin Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. AstraZeneca Basic Information, Rosuvastatin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. AstraZeneca Rosuvastatin Drugs Product Portfolios and Specifications
Table 82. AstraZeneca Rosuvastatin Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. AstraZeneca Main Business
Table 84. AstraZeneca Latest Developments
Table 85. Watson Basic Information, Rosuvastatin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Watson Rosuvastatin Drugs Product Portfolios and Specifications
Table 87. Watson Rosuvastatin Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Watson Main Business
Table 89. Watson Latest Developments
Table 90. ANGITA Basic Information, Rosuvastatin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. ANGITA Rosuvastatin Drugs Product Portfolios and Specifications
Table 92. ANGITA Rosuvastatin Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. ANGITA Main Business
Table 94. ANGITA Latest Developments
Table 95. Sun Pharmaceutical Industries Basic Information, Rosuvastatin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Sun Pharmaceutical Industries Rosuvastatin Drugs Product Portfolios and Specifications
Table 97. Sun Pharmaceutical Industries Rosuvastatin Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Sun Pharmaceutical Industries Main Business
Table 99. Sun Pharmaceutical Industries Latest Developments
LIST OF FIGURES
Figure 1. Picture of Rosuvastatin Drugs
Figure 2. Rosuvastatin Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rosuvastatin Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Rosuvastatin Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rosuvastatin Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 5 mg Tablet
Figure 10. Product Picture of 10 mg Tablet
Figure 11. Product Picture of 20 mg Tablet
Figure 12. Product Picture of 40 mg Tablet
Figure 13. Global Rosuvastatin Drugs Sales Market Share by Type in 2022
Figure 14. Global Rosuvastatin Drugs Revenue Market Share by Type (2018-2023)
Figure 15. Rosuvastatin Drugs Consumed in Hyperlipidemia And Mixed Dyslipidemia
Figure 16. Global Rosuvastatin Drugs Market: Hyperlipidemia And Mixed Dyslipidemia (2018-2023) & (K Units)
Figure 17. Rosuvastatin Drugs Consumed in Familial Hypercholesterolemia
Figure 18. Global Rosuvastatin Drugs Market: Familial Hypercholesterolemia (2018-2023) & (K Units)
Figure 19. Rosuvastatin Drugs Consumed in Hypertriglyceridemia
Figure 20. Global Rosuvastatin Drugs Market: Hypertriglyceridemia (2018-2023) & (K Units)
Figure 21. Rosuvastatin Drugs Consumed in Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
Figure 22. Global Rosuvastatin Drugs Market: Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) (2018-2023) & (K Units)
Figure 23. Rosuvastatin Drugs Consumed in Atherosclerosis
Figure 24. Global Rosuvastatin Drugs Market: Atherosclerosis (2018-2023) & (K Units)
Figure 25. Rosuvastatin Drugs Consumed in Others
Figure 26. Global Rosuvastatin Drugs Market: Others (2018-2023) & (K Units)
Figure 27. Global Rosuvastatin Drugs Sales Market Share by Application (2022)
Figure 28. Global Rosuvastatin Drugs Revenue Market Share by Application in 2022
Figure 29. Rosuvastatin Drugs Sales Market by Company in 2022 (K Units)
Figure 30. Global Rosuvastatin Drugs Sales Market Share by Company in 2022
Figure 31. Rosuvastatin Drugs Revenue Market by Company in 2022 ($ Million)
Figure 32. Global Rosuvastatin Drugs Revenue Market Share by Company in 2022
Figure 33. Global Rosuvastatin Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 34. Global Rosuvastatin Drugs Revenue Market Share by Geographic Region in 2022
Figure 35. Americas Rosuvastatin Drugs Sales 2018-2023 (K Units)
Figure 36. Americas Rosuvastatin Drugs Revenue 2018-2023 ($ Millions)
Figure 37. APAC Rosuvastatin Drugs Sales 2018-2023 (K Units)
Figure 38. APAC Rosuvastatin Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Europe Rosuvastatin Drugs Sales 2018-2023 (K Units)
Figure 40. Europe Rosuvastatin Drugs Revenue 2018-2023 ($ Millions)
Figure 41. Middle East & Africa Rosuvastatin Drugs Sales 2018-2023 (K Units)
Figure 42. Middle East & Africa Rosuvastatin Drugs Revenue 2018-2023 ($ Millions)
Figure 43. Americas Rosuvastatin Drugs Sales Market Share by Country in 2022
Figure 44. Americas Rosuvastatin Drugs Revenue Market Share by Country in 2022
Figure 45. Americas Rosuvastatin Drugs Sales Market Share by Type (2018-2023)
Figure 46. Americas Rosuvastatin Drugs Sales Market Share by Application (2018-2023)
Figure 47. United States Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Canada Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. Mexico Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Brazil Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. APAC Rosuvastatin Drugs Sales Market Share by Region in 2022
Figure 52. APAC Rosuvastatin Drugs Revenue Market Share by Regions in 2022
Figure 53. APAC Rosuvastatin Drugs Sales Market Share by Type (2018-2023)
Figure 54. APAC Rosuvastatin Drugs Sales Market Share by Application (2018-2023)
Figure 55. China Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Japan Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. South Korea Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Southeast Asia Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. India Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Australia Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. China Taiwan Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Europe Rosuvastatin Drugs Sales Market Share by Country in 2022
Figure 63. Europe Rosuvastatin Drugs Revenue Market Share by Country in 2022
Figure 64. Europe Rosuvastatin Drugs Sales Market Share by Type (2018-2023)
Figure 65. Europe Rosuvastatin Drugs Sales Market Share by Application (2018-2023)
Figure 66. Germany Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. France Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. UK Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Italy Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Russia Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. Middle East & Africa Rosuvastatin Drugs Sales Market Share by Country in 2022
Figure 72. Middle East & Africa Rosuvastatin Drugs Revenue Market Share by Country in 2022
Figure 73. Middle East & Africa Rosuvastatin Drugs Sales Market Share by Type (2018-2023)
Figure 74. Middle East & Africa Rosuvastatin Drugs Sales Market Share by Application (2018-2023)
Figure 75. Egypt Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. South Africa Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 77. Israel Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 78. Turkey Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 79. GCC Country Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 80. Manufacturing Cost Structure Analysis of Rosuvastatin Drugs in 2022
Figure 81. Manufacturing Process Analysis of Rosuvastatin Drugs
Figure 82. Industry Chain Structure of Rosuvastatin Drugs
Figure 83. Channels of Distribution
Figure 84. Global Rosuvastatin Drugs Sales Market Forecast by Region (2024-2029)
Figure 85. Global Rosuvastatin Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 86. Global Rosuvastatin Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 87. Global Rosuvastatin Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 88. Global Rosuvastatin Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 89. Global Rosuvastatin Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Rosuvastatin Drugs
Figure 2. Rosuvastatin Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rosuvastatin Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Rosuvastatin Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rosuvastatin Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 5 mg Tablet
Figure 10. Product Picture of 10 mg Tablet
Figure 11. Product Picture of 20 mg Tablet
Figure 12. Product Picture of 40 mg Tablet
Figure 13. Global Rosuvastatin Drugs Sales Market Share by Type in 2022
Figure 14. Global Rosuvastatin Drugs Revenue Market Share by Type (2018-2023)
Figure 15. Rosuvastatin Drugs Consumed in Hyperlipidemia And Mixed Dyslipidemia
Figure 16. Global Rosuvastatin Drugs Market: Hyperlipidemia And Mixed Dyslipidemia (2018-2023) & (K Units)
Figure 17. Rosuvastatin Drugs Consumed in Familial Hypercholesterolemia
Figure 18. Global Rosuvastatin Drugs Market: Familial Hypercholesterolemia (2018-2023) & (K Units)
Figure 19. Rosuvastatin Drugs Consumed in Hypertriglyceridemia
Figure 20. Global Rosuvastatin Drugs Market: Hypertriglyceridemia (2018-2023) & (K Units)
Figure 21. Rosuvastatin Drugs Consumed in Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
Figure 22. Global Rosuvastatin Drugs Market: Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) (2018-2023) & (K Units)
Figure 23. Rosuvastatin Drugs Consumed in Atherosclerosis
Figure 24. Global Rosuvastatin Drugs Market: Atherosclerosis (2018-2023) & (K Units)
Figure 25. Rosuvastatin Drugs Consumed in Others
Figure 26. Global Rosuvastatin Drugs Market: Others (2018-2023) & (K Units)
Figure 27. Global Rosuvastatin Drugs Sales Market Share by Application (2022)
Figure 28. Global Rosuvastatin Drugs Revenue Market Share by Application in 2022
Figure 29. Rosuvastatin Drugs Sales Market by Company in 2022 (K Units)
Figure 30. Global Rosuvastatin Drugs Sales Market Share by Company in 2022
Figure 31. Rosuvastatin Drugs Revenue Market by Company in 2022 ($ Million)
Figure 32. Global Rosuvastatin Drugs Revenue Market Share by Company in 2022
Figure 33. Global Rosuvastatin Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 34. Global Rosuvastatin Drugs Revenue Market Share by Geographic Region in 2022
Figure 35. Americas Rosuvastatin Drugs Sales 2018-2023 (K Units)
Figure 36. Americas Rosuvastatin Drugs Revenue 2018-2023 ($ Millions)
Figure 37. APAC Rosuvastatin Drugs Sales 2018-2023 (K Units)
Figure 38. APAC Rosuvastatin Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Europe Rosuvastatin Drugs Sales 2018-2023 (K Units)
Figure 40. Europe Rosuvastatin Drugs Revenue 2018-2023 ($ Millions)
Figure 41. Middle East & Africa Rosuvastatin Drugs Sales 2018-2023 (K Units)
Figure 42. Middle East & Africa Rosuvastatin Drugs Revenue 2018-2023 ($ Millions)
Figure 43. Americas Rosuvastatin Drugs Sales Market Share by Country in 2022
Figure 44. Americas Rosuvastatin Drugs Revenue Market Share by Country in 2022
Figure 45. Americas Rosuvastatin Drugs Sales Market Share by Type (2018-2023)
Figure 46. Americas Rosuvastatin Drugs Sales Market Share by Application (2018-2023)
Figure 47. United States Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Canada Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. Mexico Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Brazil Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. APAC Rosuvastatin Drugs Sales Market Share by Region in 2022
Figure 52. APAC Rosuvastatin Drugs Revenue Market Share by Regions in 2022
Figure 53. APAC Rosuvastatin Drugs Sales Market Share by Type (2018-2023)
Figure 54. APAC Rosuvastatin Drugs Sales Market Share by Application (2018-2023)
Figure 55. China Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Japan Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. South Korea Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Southeast Asia Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. India Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Australia Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. China Taiwan Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Europe Rosuvastatin Drugs Sales Market Share by Country in 2022
Figure 63. Europe Rosuvastatin Drugs Revenue Market Share by Country in 2022
Figure 64. Europe Rosuvastatin Drugs Sales Market Share by Type (2018-2023)
Figure 65. Europe Rosuvastatin Drugs Sales Market Share by Application (2018-2023)
Figure 66. Germany Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. France Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. UK Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Italy Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Russia Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. Middle East & Africa Rosuvastatin Drugs Sales Market Share by Country in 2022
Figure 72. Middle East & Africa Rosuvastatin Drugs Revenue Market Share by Country in 2022
Figure 73. Middle East & Africa Rosuvastatin Drugs Sales Market Share by Type (2018-2023)
Figure 74. Middle East & Africa Rosuvastatin Drugs Sales Market Share by Application (2018-2023)
Figure 75. Egypt Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. South Africa Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 77. Israel Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 78. Turkey Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 79. GCC Country Rosuvastatin Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 80. Manufacturing Cost Structure Analysis of Rosuvastatin Drugs in 2022
Figure 81. Manufacturing Process Analysis of Rosuvastatin Drugs
Figure 82. Industry Chain Structure of Rosuvastatin Drugs
Figure 83. Channels of Distribution
Figure 84. Global Rosuvastatin Drugs Sales Market Forecast by Region (2024-2029)
Figure 85. Global Rosuvastatin Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 86. Global Rosuvastatin Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 87. Global Rosuvastatin Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 88. Global Rosuvastatin Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 89. Global Rosuvastatin Drugs Revenue Market Share Forecast by Application (2024-2029)
